FDA Import Refusal AEK-9302269-4/41/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment AEK-9302269-4/41/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Jun 30, 2021. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 30, 2021
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75